Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection
Annika Rössler, Ludwig Knabl, Dorotheé von Laer, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 18, pp. 1764-1766
Open Access | Times Cited: 88

Showing 51-75 of 88 citing articles:

Omicron COVID-19 Immune Correlates Analysis of a Third Dose of mRNA-1273 in the COVE Trial
Bo Zhang, Youyi Fong, Jonathan Fintzi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity
Emma Chang-Rabley, Menno C. van Zelm, Emily Ricotta, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 675-675
Open Access | Times Cited: 1
Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial
Bo Zhang, Youyi Fong, Jonathan Fintzi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Fully understanding the efficacy profile of the COVID-19 vaccination and its associated factors in multiple real-world settings
Yunes Panahi, Behzad Einollahi, Fatemeh Beiraghdar, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Omicron Infection Evokes Cross-Protection against SARS-CoV-2 Variants in Vaccinees
Gabriele Anichini, Chiara Terrosi, Claudia Gandolfo, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 808-808
Open Access | Times Cited: 7
SARS-CoV-2 omicron variant clearance delayed in breakthrough cases with elevated fasting blood glucose
Xiujun Zhang, Guocan Si, Huifen Lu, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 7
Omicron variant of SARS-CoV-2 infection elicits cross-protective immunity in people who received boosters or infected with variant strains
Selia Chowdhury, Md. Shahraj Chowdhury, Nurjahan Shipa Chowdhury, et al.
International Journal of Immunopathology and Pharmacology (2022) Vol. 36, pp. 039463202211330-039463202211330
Open Access | Times Cited: 7
Six-Month Follow-Up of Immune Responses after a Rapid Mass Vaccination against SARS-CoV-2 with BNT162b2 in the District of Schwaz/Austria
Zoltán Bánki, Lisa Seekircher, Barbara Falkensammer, et al.
Viruses (2022) Vol. 14, Iss. 8, pp. 1642-1642
Open Access | Times Cited: 6
Vaccine- and Breakthrough Infection-Elicited Pre-Omicron Immunity More Effectively Neutralizes Omicron BA.1, BA.2, BA.4 and BA.5 Than Pre-Omicron Infection Alone
Eveline Santos da Silva, Jean-Yves Servais, Michel Kohnen, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 2, pp. 1741-1761
Open Access | Times Cited: 3
Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography
Annika Rössler, Antonia Netzl, Ludwig Knabl, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Omicron Breakthrough Infection After Heterologous Prime-Boost Vaccination Induces a Vigorous Antibody Response
Augusto Varese, Bianca Mazzitelli, Fernando Erra Díaz, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 10, pp. 1717-1720
Open Access | Times Cited: 5
Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa
Kaiyuan Sun, Stefano Tempia, Jackie Kleynhans, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Development of a Novel Medium Throughput Flow-Cytometry Based Micro-Neutralisation Test for SARS-CoV-2 with Applications in Clinical Vaccine Trials and Antibody Screening
Sophie O’Reilly, Grace Kenny, Tamara Alrawahneh, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Longitudinal Analysis of Coronavirus-Neutralizing Activity in COVID-19 Patients
Florian D. Hastert, Lisa Henß, Christine von Rhein, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 882-882
Open Access | Times Cited: 4
Antibody Response against Circulating Omicron Variants 8 Months after the Third Dose of mRNA Vaccine
Gabriele Anichini, Chiara Terrosi, Gianni Gori Savellini, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1512-1512
Open Access | Times Cited: 4
Extensive neutralization against SARS-CoV-2 variants elicited by Omicron-specific subunit vaccine as a heterologous booster
Pai Peng, Chengqian Feng, Jie Hu, et al.
iScience (2022) Vol. 25, Iss. 11, pp. 105465-105465
Open Access | Times Cited: 4
Safety and immunogenicity of heterologous ChAdOx1-nCoV19 and BNT162b2 vaccination: A meta-analysis of the heterologous COVID-19 vaccination outcomes
Yuxuan Hu, Yanning Wang, Taihang Shao, et al.
Vaccine (2023) Vol. 41, Iss. 18, pp. 3003-3010
Open Access | Times Cited: 2
Machine Learning to Identify Critical Biomarker Profiles in New SARS-CoV-2 Variants
Christoph Schatz, Ludwig Knabl, Hye‐Kyung Lee, et al.
Microorganisms (2024) Vol. 12, Iss. 4, pp. 798-798
Open Access
COVID-19 vaccines and their impact: An overview
Ka Wa Khong, Ivan Fan‐Ngai Hung
Elsevier eBooks (2024), pp. 379-388
Closed Access
SARS-CoV-2-Neutralizing Antibodies
Yawen Liu, Jianhui Nie
Vaccines (2024) Vol. 12, Iss. 11, pp. 1256-1256
Open Access
Exploring the Role of Serology Testing to Strengthen Vaccination Initiatives and Policies for COVID-19 in Asia Pacific Countries and Territories: A Discussion Paper
Tawee Chotpitayasunondh, Dale Fisher, Po‐Ren Hsueh, et al.
International Journal of Translational Medicine (2022) Vol. 2, Iss. 3, pp. 275-308
Open Access | Times Cited: 3
High-Throughput Molecular Dynamics-Based Alchemical Free Energy Calculations for Predicting the Binding Free Energy Change Associated with the Selected Omicron Mutations in the Spike Receptor-Binding Domain of SARS-CoV-2
Rajendra Bhadane, Outi M. H. Salo‐Ahen
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2779-2779
Open Access | Times Cited: 3
Understanding the challenges to COVID-19 vaccines and treatment options, herd immunity and probability of reinfection
Mohammad A. I. Al-Hatamleh, Mai Abdel Haleem Abusalah, Ma’mon M. Hatmal, et al.
Journal of Taibah University Medical Sciences (2022) Vol. 18, Iss. 3, pp. 600-638
Open Access | Times Cited: 3
Humoral Response after a Fourth Dose with mRNA-1273 in Healthcare Workers with and without a History of SARS-CoV-2 Infection and Previously Vaccinated with Two Doses of BBIBP-CorV Plus BNT162b2 Vaccine
Juan Carlos Gómez de la Torre, Miguel Hueda-Zavaleta, José Alonso Cáceres-DelAguila, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 894-894
Open Access | Times Cited: 1
Development of a novel medium throughput flow-cytometry based micro-neutralisation test for SARS-CoV-2 with applications in clinical vaccine trials and antibody screening
Sophie O’Reilly, Grace Kenny, Tamara Alrawahneh, et al.
PLoS ONE (2023) Vol. 18, Iss. 11, pp. e0294262-e0294262
Open Access | Times Cited: 1

Scroll to top